Back to search
FDAFDA · Food and drugs·Recall number D-0261-2019

Isosorbide Dinitrate Tablets, USP 20 mg,100-count bottles, Rx Only Manufactured by: Sandoz Inc., Princeton, NJ 08540 For BluePoint Laboratories, NDC 68001-222-00

Published November 21, 2018 · Recall initiated: November 2, 2018

Summary

FDA records drug Class II recall D-0261-2019, published November 21, 2018 and initiated November 2, 2018. Recalling firm: Sandoz Inc; Status: Terminated; Reported quantity: 1550 bottles; Lot: Lot #: JA9534, Exp. 05/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Cross Contamination with Other Products

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Sandoz Inc
Distributor
Nationwide within the United States
Lot
Lot #: JA9534, Exp. 05/2021
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Isosorbide Dinitrate Tablets, USP 20 mg,100-count bottles, Rx Only Manufactured by: Sandoz Inc., Princeton, NJ 08540 For BluePoint Laboratories, NDC 68001-222-00 recalled?

Yes. FDA published recall D-0261-2019 on November 21, 2018. Reported hazard: Cross Contamination with Other Products

What should I do if I have this product?

Voluntary: Firm initiated · Letter